Johnson&Johnson (J&J) Signs a Research Collaboration with Apple for Atrial Fibrillation (AFib)

 Johnson&Johnson (J&J) Signs a Research Collaboration with Apple for Atrial Fibrillation (AFib)

Johnson&Johnson (J&J) Signs a Research Collaboration with Apple for Atrial Fibrillation (AFib)

Shots:

  • J&J and Apple collaborate to initiate a heart health program in combination with J&J’s app & Apple Watch’s irregular rhythm notifications and ECG app, for developing methods in detecting and improving QoL for patients with AFib
  • The focus of the collaboration is to measure the results of health program with rhythm notifications on Apple Watch including prevention of strokes & evaluating the effects of medication adherence program using J&J’s app
  • In H2’19, the heart health program will be launched enrolling patients aged 65 years or older with AFib in the US

Click here to read full press release/ article | Ref: J&J | Image: Market watch

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post